Capillary Electrophoresis Market Size by Segments,Country, Region, Industry-Wide Analysis, Competitive Landscape Assessment & Long-Term Forecast to 2032
Overview
Capillary Electrophoresis Market size was valued at US$387.12 Mn. in 2025 and the total revenue is expected to grow at a CAGR of5.92% through 2026 to 2032, reaching nearly US$ 579.02 Mn.
Global Capillary Electrophoresis Market Overview:
Capillary electrophoresis is a group of electrokinetic separation techniques used in capillaries with submillimeter diameters and microfluidic and nanofluidic channels. In terms of speed, resolution, sensitivity, and data management, capillary electrophoresis has a number of benefits over slab gel separations. Capillary Zone Electrophoresis, Capillary Gel Electrophoresis, and Capillary Electrochromatography are the techniques of the capillary electrophoresis. Agarose Gel Electrophoresis, and Polyacrylamide Gel Electrophoresis are the gel types of the capillary electrophoresis. Academic & Research Institutes, and Diagnostics Laboratories are some of the end-users of the capillary electrophoresis. The Global Capillary Electrophoresis Market is expected to grow at a CAGR of 5.92% during the forecast period 2026-2032.
To know about the Research Methodology :- Request Free Sample Report
Capillary Electrophoresis Market Dynamics:
During the forecast period 2026-2032, the high growth in funding for proteomic and genomic research and electrophoresis techniques has been driving the market and is functioning as a potential driver for the capillary electrophoresis market. Infectious diseases, cancer, and genetic problems are all on the rise, which is helping to drive the target market forward.
The number of industry-academic research collaborations is growing, as is the significance of nanoproteomics, as well as the rise of the number of forensic, clinical, and research laboratories, as well as the increased use of NGS and the reducing cost of DNA sequencing. Furthermore, the target market is being boosted forward by the shift in preference for genome-based drug discovery over plant-based drug development. Moreover, the rising need for personalised medicine and significant growth potential in developing countries are expected to flourish numerous growth opportunities for the capillary electrophoresis market over the forecast period.
The presence of alternatives with improved efficiency and outcomes, as well as long and complex operations, are expected to restrains the growth of the capillary electrophoresis market during the forecast period 2026-2032. The increased safety issues associated with electrophoresis reagents would offer a hindrance to the market's growth during the forecast period.
Capillary Electrophoresis Market Segment Analysis:
Based on the Technique, the market is segmented into the Capillary Zone Electrophoresis, Gel Electrophoresis, and Capillary Electro chromatography. The market segment is expected to hold the largest market share of 6.17% by 2032. Capillary zone electrophoresis' capacity to assess the size and amount of protein and nucleic acid across a serum sample leads to a variety of therapeutic applications for this technology. Capillary zone electrophoresis is a method for assessing protein and nucleic acid purity and amount of expression, as well as producing antibodies that produces flawless findings. These factors are driving the capillary electrophoresis market segment during the forecast period.
In forensics, genetics, biotechnology, and molecular biology laboratories, capillary zone electrophoresis is extensively utilised to aid achieve a quick result. In HIV tests, capillary zone electrophoresis is used to separate protein and nucleic acids and assess post-translational changes.
Based on the Gel Type, the market is segmented into Agarose Gel Electrophoresis, and Polyacrylamide Gel Electrophoresis. Agarose Gel Electrophoresis segment is expected to grow rapidly at a CAGR of 6.23% during the forecast period 2026-2032. In the field of biotechnology, agarose gel electrophoresis is a common method. Purification of DNA is driving the market segment during the forecast period, due to the large range of Agarose gel electrophoresis that assesses the quality and quantity of DNA. This straightforward but exact analytical approach is commonly employed in research, biomedical, and forensic laboratories, as well as biotechnology institutes. As a result, end-user demand for Agarose gel electrophoresis is increasing.
Based on the End User, the market is segmented into Academic & Research Institutes, Diagnostics Laboratories, and Others. Academic & Research Institutes segment is expected to grow rapidly at a CAGR of 5.93% during the forecast period 2026-2032. Patients suffering from chronic or heredity disorders can have detailed DNA and RNA expression analysis performed with the help of protein and nucleic acid electrophoresis to meet the unmet demand of personalized medicine.
Diagnostics Laboratories segment is expected to grow rapidly at a CAGR of 6.11% during the forecast period 2026-2032. The rising number of cancer patients, as well as the need to discover biomarkers and tailored cancer therapies, presents a profitable market opportunity for the global market. Electrophoresis equipment and consumables are becoming more popular as a result of Next-Generation Sequencing. The widespread availability of gel kits in laboratories and research institutes around the world is a main driving factor behind the global market's growth.
Capillary electrophoresis, or CE, is widely used in molecular diagnostic procedures. The analysis of nucleic acids is enhanced by automation, microvolume samples, greater sensitivity, fast detection, and the computerization given by CE. CE also comes with a multiple fluorescence detecting system, which is useful.
In forensics, paternity testing, bone marrow engraftment analysis, and other identifying procedures, CE analysis of short tandem repeat polymorphisms is used. CE is frequently used in other tests for genetic disease diagnosis, oncology investigations, and DNA sequencing. It is used in DNA sequencing to separate nucleotides labelled with different coloured fluorescent dyes; CE and these markers allow for automated nucleotide sequence determination of DNA segments.
Regional Insights:
North America region is expected to dominate the Capillary Electrophoresis market during the forecast period 2026-2032. North America region is expected to hold the largest market share of 5.93% by 2032. The use of newer delivery models in labs diagnostics, as well as the changing healthcare business, have driven the global market's rise over the forecast period.
Large expenditures in the healthcare industry for the adoption of requisite modern technologies and professional training to bring this market up to level with developed nations while keeping costs low are needed to bring this market up to par with developed countries while keeping costs low. Professionals utilise protein and nucleic acid electrophoresis to maintain diagnosis and testing result standards, which helps to boost the global market in this region. During the forecast period, the market is driven by the growing elderly population and the rising number of patients with chronic diseases caused by inherited disorders.
Capillary Electrophoresis Market Recent Developments:
| Exact Date | Company | Development | Impact |
|---|---|---|---|
| 04 February 2026 | QIAGEN N.V. | QIAGEN officially launched the QIAsprint Connect, a next-generation high-throughput system designed for automated sample processing. | The system addresses the rising demand for workflow standardization and high-volume processing in liquid biopsy and microbiome research. |
| 12 January 2026 | QIAGEN N.V. | QIAGEN finalized the integration of Parse Biosciences, incorporating instrument-free single-cell analysis into its portfolio. | This acquisition expands QIAGEN's capabilities in genomic research, expected to contribute roughly $40 million in sales for the 2026 fiscal year. |
| 22 December 2025 | Thermo Fisher Scientific | Thermo Fisher showcased its Applied Biosystems SeqStudio Flex Dx, an IVDR-compliant capillary electrophoresis (CE) system. | The system provides clinical labs with a validated pathway for Sanger sequencing and fragment analysis, crucial for targeted genomic testing. |
| 04 November 2025 | Agilent Technologies | Agilent announced the commercial release of the ProteoAnalyzer system, an automated parallel CE platform for complex protein mixtures. | The platform reduces manual intervention in protein stability and purity assessments, optimizing efficiency for biopharmaceutical R&D. |
| 24 January 2025 | Sebia | Sebia presented its CAPILLARYS 3 TERA platform at Medlab 2025, emphasizing its high-throughput hemoglobinopathy screening. | Enhanced smart reagent management and scalable diagnostic modules help clinical labs manage rising chronic disease burdens more effectively. |
| 12 January 2025 | Shimadzu Corporation | Shimadzu reported significant growth in its Analytical & Measuring Instruments segment, reaching 247.9 billion JPY in net sales. | The strong financial performance underscores the global reliance on high-efficiency separation technologies for industrial and pharmaceutical applications. |
The objective of the report is to present a comprehensive analysis of the Global Capillary Electrophoresis Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.
PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.
The reports also help in understanding the Global Capillary Electrophoresis Market dynamic, structure by analyzing the market segments and project the Global Capillary Electrophoresis Market size. Clear representation of competitive analysis of key players by Type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Capillary Electrophoresis Market make the report investor’s guide.
Capillary Electrophoresis Market Scope: Inquiry Before Buying
| Global Capillary Electrophoresis Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2025 | Forecast Period: | 2026-2032 |
| Historical Data: | 2020 to 2025 | Market Size in 2025: | 387.12 USD Mn |
| Forecast Period 2026-2032 CAGR: | 5.92% | Market Size in 2032: | 579.02 USD Mn |
| Segments Covered: | by Product | Instrument Automatic Capillary Electrophoresis Systems Semi-Automatic Capillary Electrophoresis Systems Consumables Software |
|
| by Mode | Capillary zone electrophoresis Capillary gel electrophoresis Capillary electrochromatography |
||
| by Application | Nucleic acid analysis Protein analysis Genomic DNA Plasmid DNA Fragment Analysis RNA/mRNA Analysis Others |
||
| by End-use | Research Organizations and Institutes Pharmaceutical & Biotechnology Companies Clinical laboratories |
||
Capillary Electrophoresis Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Capillary Electrophoresis Market Key Players
- Agilent Technologies
- Thermo Fisher Scientific
- Bio‑Rad Laboratories
- Danaher Corporation
- PerkinElmer, Inc.
- QIAGEN
- Merck KGaA
- Shimadzu Corporation
- Beckman Coulter, Inc.
- SEBIA
- Bio‑Techne (inc. brands under Bio‑Techne)
- AB Sciex
- Lumex Instruments
- LABGENE Scientific SA
- Biotron Healthcare
- Prince Technologies
- LONZA
- Teledyne Technologies Incorporated
- Harward Biosciences
- Helena Laboratories Corporation
- TBG Diagnostics Ltd.
- VWR International
Others